Navigation Links
New Study Finds that Timing of Brand Activities is a Key Component of an Effective Global Branding Process for New Pharmaceutical Products
Date:3/4/2017

CHAPEL HILL, N.C., March 3, 2017 /PRNewswire/ -- Pharmaceutical companies struggle to create global branding that will work across geographies and affiliates.

The timing of brand activities is a key component of an effective global branding process that will work across geographies and affiliates, according to new research from consulting firm Best Practices, LLC.

In the study, participants favored initially handing over 7 of 8 key branding elements to affiliates during the Phase III Data to NDA Filing period. This timing allows for global and affiliates to create brand element alignment over consequent months, with both sides completing the handover in the next periods, Filing to Registration (42% complete) and Registration/Approval to Launch (58% complete).

The study, Best Practices in Global Branding for New Products: Creating an Effective Global Brand for New Products and Ensuring Alignment across Geographies and Affiliates, can help brand leaders more effectively navigate the global branding process to ensure a successful global launch of a new product. 

The study contains current insights from leading pharmaceutical companies on questions such as:

  • When are companies starting and finishing key global branding activities such as tradename identification, positioning, message development and brand personality?
  • What functional groups are leading these branding activities and who has sign-off responsibilities?
  • How do organizations ensure their global branding elements meet affiliates' needs?
  • How much are agencies utilized for the different branding activities?
  • What are the agency costs associated with positioning and message development?

The full 76-page report contains hundreds of benchmark metrics and dozens of narratives from veteran branding leaders to provide executives with the tools, tactics and techniques to help organizations develop a successful global branding program.

Review a complimentary summary of the study at http://www.best-in-class.com/rr1442.htm.

The report is based on an extensive primary research project involving 18 branding leaders from pharmaceutical organizations. Pharmaceutical leaders can use this study to see how their global branding process compares with industry trends and averages.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-study-finds-that-timing-of-brand-activities-is-a-key-component-of-an-effective-global-branding-process-for-new-pharmaceutical-products-300417924.html


'/>"/>
SOURCE Best Practices, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Advocacy Study Highlights Top Locations for High-Growth Companies
2. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
3. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
4. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
5. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
6. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
7. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
8. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
9. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
10. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
11. Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2019)... , ... September 11, 2019 , ... ... headquartered in Irving, Texas, that exclusively serves premier oral and maxillofacial surgeons – ... an oral and maxillofacial surgery practice with three locations in the Atlanta area. ...
(Date:9/11/2019)... ... September 11, 2019 , ... Genedata, the leading ... globally operating Finnish pharmaceutical company, has licensed Genedata Biologics® to support their R&D ... , “As part of our strategy to expand our biopharmaceutical R&D operations, ...
(Date:9/11/2019)... ... September 10, 2019 , ... Women’s Excellence is pleased ... recognition of Breast Cancer Awareness Month. In additional to standard weekly appointments, Women's ... 26, 2019 , Women’s Excellence has earned ACR accreditation for mammography services. The ...
Breaking Medicine Technology:
(Date:9/8/2019)... , ... September 06, 2019 , ... ... a historic milestone as its fall 2019 enrollment has reached an all-time high ... students) in master’s and doctoral level candidates, totaling 374 students. The total does ...
(Date:9/8/2019)... ... September 06, 2019 , ... The Plantrician Project is pleased to introduce ... Nutrition Healthcare Conference, where close to 1000 medical professionals from 25 countries, will ... to the use of whole food, plant-based nutrition in clinical practice. ...
(Date:9/8/2019)... ... September 07, 2019 , ... Messaging Architects, an eMazzanti Technologies ... recent successful GroupWise to Office 365 email migration on the Messaging Architects website. ... healthcare organization. , The informative article discusses the tight timeline faced by the ...
(Date:9/4/2019)... ... September 04, 2019 , ... Strategic Radiology has engaged Dan ... practices, representing 28 group practices and more than 1,100 radiologists. , Schriger is ... health care. From 2013 until recently, Dan was director of sales and business ...
(Date:9/4/2019)... ... September 04, 2019 , ... R3 Stem ... 18-19th, 2019. The nation's leading hands-on regenerative training course includes two days of ... is $1000 off, and each attendee also receives a free stem cell procedure ...
Breaking Medicine News(10 mins):